Update on the Use of Biologics in Lupus

ISSN: 1873-4316 (Online)
ISSN: 1389-2010 (Print)

Volume 17, 15 Issues, 2016

Download PDF Flyer

Current Pharmaceutical Biotechnology

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 152nd of 255 in Pharmacology & Pharmacy
  • 213th of 290 in Biochemistry & Molecular Biology

Submit Abstracts Online Submit Manuscripts Online

Zeno Foldes-Papp
Christian Clinical Center Siegen-Kreuztal

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 1.802
5 - Year: 2.327

Update on the Use of Biologics in Lupus

Current Pharmaceutical Biotechnology, 15(6): 516-520.

Author(s): Manisha Relan, Sahana Vishwanath, Long Shen and Julian L Ambrus Jr.

Affiliation: Room C281, Buffalo General Hospital, 100 High Street, Buffalo, NY 14203, USA.


Systemic lupus erythematosus is more than a heterogeneous autoimmune disease. It is in fact a syndrome of many different clinical genotypes and phenotypes. This review covers the most recently studied monoclonal antibodies and those currently being investigated. The key trials are summarized, including those for biologics on the market for two decades and those just approved for lupus less than two years ago. The focus will be on the following four: Rituximab, Abatacept, Belimumab, and Epratuzumab. It is a challenge to design the perfect trial and study patients with this disease as each has his or her own unique manifestations, biological markers, and underlying genetic background. However, as our understanding of the immune mechanisms involved in lupus increases; novel therapies will emerge that can be utilized for appropriately selected patients.


Antibodies, biologics, lupus, monoclonal antibody, SLE, systemic lupus erythematosus, treatment.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 15
Issue Number: 6
First Page: 516
Last Page: 520
Page Count: 5
DOI: 10.2174/1389201015666140804162053
Price: $58
Pharmaceutical Microbiology 2017

Related Journals

Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science